Literature DB >> 19148475

Mutation of PIK3CA: possible risk factor for cervical carcinogenesis in older women.

Baoxia Cui1, Biying Zheng, Xi Zhang, Ulf Stendahl, Sonia Andersson, Keng-Ling Wallin.   

Abstract

PIK3CA encodes the p110alpha catalytic subunit of PI 3-kinase, which regulates signaling pathways important for neoplasia, cell proliferation and apoptosis. Somatic mutations in this gene have been detected in several solid human tumors. We investigated these mutations in cervical carcinoma and its precursors, and their association with HPV infection and patient clinical data. The mutations were analyzed using post-PCR direct genomic DNA sequencing. Samples included 9 cervical cancer cell lines, 184 invasive cervical carcinomas, and 30 cervical neoplasias. Missense mutations of PIK3CA were identified in 15/184 (8.15%) invasive cervical carcinomas. One novel mutation G1638C (Q546H) was found. Three mutations were identified in the cervical cancer lines. No mutations were found in the precursors. The difference in mutation frequency between invasive and pre-invasive lesions was not significant (p=0.1372). In relation to age and HPV, the mutation rate was significantly higher in patients>or=60 years (p=0.001), while the rate of HPV infection was higher in patients<or=60 years (p=0.025). No significant correlation with other clinicopathological data was found. The results suggest that PIK3CA mutations are a late event and uncommon in the progression of malignant tumors, but it appears that they facilitate carcinogenesis in older women.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19148475

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  20 in total

Review 1.  Oncogenic mutations of PIK3CA in human cancers.

Authors:  Yardena Samuels; Todd Waldman
Journal:  Curr Top Microbiol Immunol       Date:  2010       Impact factor: 4.291

2.  MicroRNA-221 targets PTEN to reduce the sensitivity of cervical cancer cells to gefitinib through the PI3K/Akt signaling pathway.

Authors:  Juan Du; LiNa Wang; ChenXi Li; HuiLun Yang; YuanBo Li; Haiyang Hu; Hui Li; ZongFeng Zhang
Journal:  Tumour Biol       Date:  2015-10-19

3.  Homozygous deletion of the STK11/LKB1 locus and the generation of novel fusion transcripts in cervical cancer cells.

Authors:  Michael T McCabe; Doris R Powell; Wei Zhou; Paula M Vertino
Journal:  Cancer Genet Cytogenet       Date:  2010-03

4.  Genome Analysis of Latin American Cervical Cancer: Frequent Activation of the PIK3CA Pathway.

Authors:  Hong Lou; Guillermo Villagran; Joseph F Boland; Kate M Im; Sarita Polo; Weiyin Zhou; Ushie Odey; Eligia Juárez-Torres; Ingrid Medina-Martínez; Edgar Roman-Basaure; Jason Mitchell; David Roberson; Julie Sawitzke; Lisa Garland; Maria Rodríguez-Herrera; David Wells; Jennifer Troyer; Francisco Castillo Pinto; Sara Bass; Xijun Zhang; Miriam Castillo; Bert Gold; Hesler Morales; Meredith Yeager; Jaime Berumen; Enrique Alvirez; Eduardo Gharzouzi; Michael Dean
Journal:  Clin Cancer Res       Date:  2015-06-16       Impact factor: 12.531

Review 5.  Molecular Signatures of Gynecological Cancers: Clinicians Perspective.

Authors:  T S Shylasree; Bansal Richa; Gurram Lavanya; Seema Gulia
Journal:  Indian J Surg Oncol       Date:  2021-02-02

6.  Efficient blockade of Akt signaling is a determinant factor to overcome resistance to matuzumab.

Authors:  Debora D Meira; Vitor H Almeida; Jânio S Mororó; Mauricio S Caetano; Isabel P Nóbrega; Delano Batista; Cinthya Sternberg; Carlos G Ferreira
Journal:  Mol Cancer       Date:  2011-12-20       Impact factor: 27.401

7.  PIK3CA mutation analysis in Chinese patients with surgically resected cervical cancer.

Authors:  Libing Xiang; Wei Jiang; Jiajia Li; Xuxia Shen; Wentao Yang; Gong Yang; Xiaohua Wu; Huijuan Yang
Journal:  Sci Rep       Date:  2015-09-11       Impact factor: 4.379

8.  Epidermal growth factor receptor pathway mutation and expression profiles in cervical squamous cell carcinoma: therapeutic implications.

Authors:  Sureewan Bumrungthai; Kavita Munjal; Shirish Nandekar; Kumarasen Cooper; Tipaya Ekalaksananan; Chamsai Pientong; Mark Francis Evans
Journal:  J Transl Med       Date:  2015-07-25       Impact factor: 5.531

9.  Precise Classification of Cervical Carcinomas Combined with Somatic Mutation Profiling Contributes to Predicting Disease Outcome.

Authors:  Vivian M Spaans; Marjolijn D Trietsch; Alexander A W Peters; Michelle Osse; Natalja Ter Haar; Gert J Fleuren; Ekaterina S Jordanova
Journal:  PLoS One       Date:  2015-07-21       Impact factor: 3.240

10.  AKT inhibitors promote cell death in cervical cancer through disruption of mTOR signaling and glucose uptake.

Authors:  Ramachandran Rashmi; Carl DeSelm; Cynthia Helms; Anne Bowcock; Buck E Rogers; Janet L Rader; Janet Rader; Perry W Grigsby; Julie K Schwarz
Journal:  PLoS One       Date:  2014-04-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.